Results 151 to 160 of about 3,647,392 (287)

volume 21, no. 4 (October 2017) [PDF]

open access: yes, 2017
Office of Alumni Engagement, Bryant University
core   +1 more source

Cognitive Status in People With Epilepsy in the Republic of Guinea: A Prospective, Case–Control Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective People with epilepsy (PWE) may experience cognitive deficits but fail to undergo formal evaluation. This study compares cognitive status between PWE and healthy controls in the West African Republic of Guinea. Methods A cross‐sectional, case–control study was conducted in sequential recruitment phases (July 2024–July 2025) at Ignace ...
Maya L. Mastick   +14 more
wiley   +1 more source

volume 19, no. 3 (July 2016) [PDF]

open access: yes, 2016
Office of Alumni Engagement, Bryant University
core   +1 more source

Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein   +13 more
wiley   +1 more source

“Getting Engaged” [PDF]

open access: yesJournal of General Internal Medicine, 2014
Slutsky, Jean, Sheridan, Sue, Selby, Joe
openaire   +2 more sources

volume 19, no. 2 (April 2016) [PDF]

open access: yes, 2016
Office of Alumni Engagement, Bryant University
core   +1 more source

Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The practice of neurology requires an understanding of clinical ethics for decision‐making. In multiple sclerosis (MS) care, there are a wide range of ethical considerations that may arise. These involve shared decision‐making around selection of a disease‐modifying therapy (DMT), risks and benefits of well‐studied medications in comparison to
Methma Udawatta, Farrah J. Mateen
wiley   +1 more source

Engaging Iran [PDF]

open access: yesScience, 2008
Glenn, Schweitzer, Norman, Neureiter
openaire   +2 more sources

Home - About - Disclaimer - Privacy